These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 37222158)
21. Prevalence of protective haplotypes of the Favela-Mendoza AF; Rodríguez-Rodríguez BG; Rojas-Prado E; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortés G; Rangel-Villalobos H Per Med; 2021 Sep; 18(6):533-540. PubMed ID: 34674552 [TBL] [Abstract][Full Text] [Related]
22. Associations between Zhang ZH; Yue Sun LC; Gu HY; Jiang C; Yi ZM Pharmacogenomics; 2023 Jun; 24(8):475-484. PubMed ID: 37318060 [No Abstract] [Full Text] [Related]
23. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects. Ramakumari N; Indumathi B; Katkam SK; Kutala VK Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243 [TBL] [Abstract][Full Text] [Related]
24. Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients. Lee HK; Hu M; Lui SSh; Ho CS; Wong CK; Tomlinson B Pharmacogenomics; 2013 Aug; 14(11):1283-94. PubMed ID: 23930675 [TBL] [Abstract][Full Text] [Related]
25. A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance. Bigossi M; Maroteau C; Dawed AY; Taylor A; Srinivasan S; Melhem AL; Pearson ER; Pola R; Palmer CNA; Siddiqui MK Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):536-545. PubMed ID: 37253618 [TBL] [Abstract][Full Text] [Related]
26. Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites. Bai X; Zhang B; Wang P; Wang GL; Li JL; Wen DS; Long XZ; Sun HS; Liu YB; Huang M; Zhong SL Acta Pharmacol Sin; 2019 Apr; 40(4):492-499. PubMed ID: 29950617 [TBL] [Abstract][Full Text] [Related]
27. Characterizing disparities in receipt of palliative care for Asian Americans, Native Hawaiians, and Pacific Islanders with metastatic cancer in the United States. Kohli K; Kohli M; Jain B; Swami N; Ranganathan S; Chino F; Iyengar P; Yerramilli D; Dee EC Support Care Cancer; 2024 Jul; 32(8):494. PubMed ID: 38977496 [TBL] [Abstract][Full Text] [Related]
28. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics. Zhou Q; Chen QX; Ruan ZR; Yuan H; Xu HM; Zeng S Pharmazie; 2013 Mar; 68(3):187-94. PubMed ID: 23556337 [TBL] [Abstract][Full Text] [Related]
29. Racial Bias Beliefs Related to COVID-19 Among Asian Americans, Native Hawaiians, and Pacific Islanders: Findings From the COVID-19 Effects on the Mental and Physical Health of Asian Americans and Pacific Islanders Survey Study (COMPASS). Park VT; Tsoh JY; Dougan M; Nam B; Tzuang M; Park LG; Vuong QN; Bang J; Meyer OL J Med Internet Res; 2022 Aug; 24(8):e38443. PubMed ID: 35658091 [TBL] [Abstract][Full Text] [Related]
30. SLCO1B1 variants and statin-induced myopathy--a genomewide study. ; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507 [TBL] [Abstract][Full Text] [Related]
31. Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care. DeGorter MK; Tirona RG; Schwarz UI; Choi YH; Dresser GK; Suskin N; Myers K; Zou G; Iwuchukwu O; Wei WQ; Wilke RA; Hegele RA; Kim RB Circ Cardiovasc Genet; 2013 Aug; 6(4):400-8. PubMed ID: 23876492 [TBL] [Abstract][Full Text] [Related]
32. SLCO1B1 Gene Polymorphisms (rs2306283 and rs4149056) and Statin-Induced Myopathy in Jordanian Diabetics. Shahrure ZM; Irshaid YM; Mustafa KN; Abujbara MA; Al Shhab M; El-Khateeb MS; Ajlouni KM Curr Rev Clin Exp Pharmacol; 2021; 16(3):281-288. PubMed ID: 32860365 [TBL] [Abstract][Full Text] [Related]
33. Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population. Alqasrawi MN; Al-Mahayri ZN; Alblooshi H; Alsafar H; Ali BR Curr Vasc Pharmacol; 2024; 22(3):218-229. PubMed ID: 38284696 [TBL] [Abstract][Full Text] [Related]
34. SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study. Liu JE; Liu XY; Chen S; Zhang Y; Cai LY; Yang M; Lai WH; Ren B; Zhong SL Eur J Clin Pharmacol; 2017 Nov; 73(11):1409-1416. PubMed ID: 28812116 [TBL] [Abstract][Full Text] [Related]
35. Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactions. Sainz de Medrano Sainz JI; Brunet Serra M Adv Lab Med; 2023 Dec; 4(4):341-352. PubMed ID: 38106499 [TBL] [Abstract][Full Text] [Related]
36. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics. Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685 [TBL] [Abstract][Full Text] [Related]
38. Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy. Ahangari N; Doosti M; Ghayour Mobarhan M; Sahebkar A; Ferns GA; Pasdar A Ann Med; 2020 Dec; 52(8):462-470. PubMed ID: 32735150 [TBL] [Abstract][Full Text] [Related]